Human NIRF (UHRF2) activation kit by CRISPRa

CAT#: GA114528

UHRF2 CRISPRa kit - CRISPR gene activation of human ubiquitin like with PHD and ring finger domains 2



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
UHRF2 (Myc-DDK-tagged)-Human ubiquitin-like with PHD and ring finger domains 2 (UHRF2)
    • 10 ug

CNY 5,872.00
CNY 8,460.00


UHRF2 mouse monoclonal antibody,clone OTI4E10
    • 100 ul

CNY 1,999.00
CNY 2,700.00


UHRF2 mouse monoclonal antibody,clone OTI4G10
    • 30 ul

CNY 800.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol UHRF2
Locus ID 115426
Kit Components

GA114528G1, NIRF gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA114528G2, NIRF gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA114528G3, NIRF gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Reference Data
RefSeq NM_152306, NM_152896, NR_046386
Synonyms NIRF, URF2, RNF107, MGC33463, DKFZp434B0920, DKFZp686G0837, RP11-472F14.2
Summary This gene encodes a nuclear protein which is involved in cell-cycle regulation. The encoded protein is a ubiquitin-ligase capable of ubiquinating PCNP (PEST-containing nuclear protein), and together they may play a role in tumorigenesis. The encoded protein contains an NIRF_N domain, a PHD finger, a set- and ring-associated (SRA) domain, and a RING finger domain and several of these domains have been shown to be essential for the regulation of cell proliferation. This protein may also have a role in intranuclear degradation of polyglutamine aggregates. Alternative splicing results in multiple transcript variants some of which are non-protein coding. [provided by RefSeq, Feb 2012]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...